Biopharma consultant with extensive leadership experience in transforming clinical potential into commercial success. Provided strategic counsel for the industry’s leading biopharmaceutical companies working across multiple therapeutic areas, through all phases of the product lifecycle. Held P&L responsibility for a $1.5Bn US oncology franchise, secured licensing investments of over $350M, and developed a product portfolio with a PYS of >$5Bn. Today, as managing partner and principal consultant for Eyecatcher, he uncovers critical insights to ensure clinical studies demonstrate meaningful differentiation and value and that phase 3 programs are optimally designed for successful commercialization. Specifically, programs guide cross-functional development and commercial teams all along the patient journey, building in critical insights from healthcare professionals and payors along the way. Other services offered include brand strategy, development and validation of target product profiles, market research, payer value proposition, global market access, and payer evidence planning as well as assessments and ongoing competitive intelligence reporting and forecasting.